Effect of 4‐(Diethylamino)benzaldehyde on Ethanol Metabolism in Mice

Mahmoud I.E. Mahmoud, James J. Potter, O. Michael Colvin, John Hilton, Esteban Mezey

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


The compound 4‐(diethylamino)benzaldehyde (DEAB) is a potent inhibitor of cytosolic (class 1) aldehyde dehydrogenase (ALDH) in vitro and can overcome cyclophosphamide resistance in murine leukemia cells characterized by their high content of ALDH. In this study, we examined the in vivo effect of DEAB in mice on ethanol metabolism and on antipyrine clearance as a measure of the microsomal mixed function oxidase activity. DEAB administered in doses of 50 and 100 mg/kg increased the blood acetaldehyde concentration and decreased the plasma acetate concentration in mice treated with ethanol. A pharmacokinetic approach demonstrated that DEAB in doses of 50 and 100 mg/kg inhibited the fraction of ethanol converted to acetate by 32.5 and 67.5%, respectively. This inhibition was comparable with that produced by disulfiram. DEAB produced optimal inhibition of ALDH 10–15 min after administration. DEAB did not change the half‐life or the total clearance of antipyrine. We conclude that DEAB is a potent inhibitor of ALDH in vivo and has no effect on the mixed function oxidase activity as determined by antipyrine clearance.

Original languageEnglish (US)
Pages (from-to)1223-1227
Number of pages5
JournalAlcoholism: Clinical and Experimental Research
Issue number6
StatePublished - Nov 1993


  • 4‐(Diethylamino)benzaldehyde
  • Acetate
  • Aldehyde Dehydrogenase
  • Ethanol

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Toxicology
  • Psychiatry and Mental health


Dive into the research topics of 'Effect of 4‐(Diethylamino)benzaldehyde on Ethanol Metabolism in Mice'. Together they form a unique fingerprint.

Cite this